Over the past two weeks, investors have been running for cover to avoid the recent bout of market volatility. One asset attracting attention as a haven in stormy waters is Bitcoin. However, while the cryptocurrency might look like an attractive investment in the current environment, it has its flaws.
Indeed, one of the reasons why Bitcoin hasn’t really taken off as an independent currency is that it’s difficult to trade. Its value is also highly volatile. The price of the cryptocurrency can move hundreds of dollars in just a few seconds. That makes it pretty unreliable as a currency.
The costs of buying and selling Bitcoin is also quite high compared to regular investments. As such, it might be better to avoid it altogether. High-quality, blue-chip income stocks could be a better investment.
There are a handful of FTSE 100 companies that seem well-placed to weather the current storm. These include consumer goods giant Unilever, which owns world-famous brands such as Ben and Jerry’s ice cream.
While the demand for such products and might drop off in the near term, from a long-term perspective, the coronavirus outbreak isn’t going to lead to a significant decline in the consumption of ice cream.
Reckitt Benckiser is another option. The owner of cleaning brands such as Dettol and Harpic is unlikely to see a sustained drop-off in demand for its products. It’s highly likely the need for cleaning products will increase in the next few months as authorities seek to slow the spread of COVID-19.
As well as defensive consumer goods companies, other businesses that provide essential products or services are likely to be better buys than Bitcoin in the medium term.
Halma, which provides health and safety equipment for multiple industries, is a great example. There will always be a demand for health and safety products, even if the sector might suffer some near-term disruption. When the economy restarts, demand should return to normal levels.
Blue-chip pharmaceutical companies, such as AstraZeneca and GlaxoSmithKline, fall into this bucket as well. Unless the COVID-19 virus wiped out the entire human population, there will always be a growing demand for healthcare services and drugs.
These two companies are some of the largest pharmaceutical groups in the world. That implies they should be able to whether the virus storm and come out the other side.
Unlike Bitcoin, all of these companies also offer regular dividend distributions. In most cases, investors have to pay to store Bitcoin. So, not only do these companies look to be better investments than Bitcoin over the long term, but they’ll also pay you while you wait for the economy to return to growth.
What’s not to like?
According to one leading industry firm, the 5G boom could create a global industry worth US $12.3 TRILLION out of thin air…
And if you click here, we’ll show you something that could be key to unlocking 5G’s full potential...
It’s just ONE innovation from a little-known US company that has quietly spent years preparing for this exact moment…
But you need to get in before the crowd catches onto this ‘sleeping giant’.
Rupert Hargreaves owns shares of Unilever. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline and Unilever. The Motley Fool UK has recommended AstraZeneca and Halma. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.